Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Timex Contract Win

14 Jun 2006 07:00

Embargoed Release: 07:00hrs Wednesday 14th June 2006 Sopheon Plc (`Sopheon') Timex Advances Innovation Strategy with Sopheon's Accolade System Leading Watchmaker Up and Running with Best-Practice Product Innovation Process in Only 60 Days Sopheon, the international software and services company, is pleased toannounce that Timex Corporation, the largest-selling wristwatch brand inAmerica, has deployed Sopheon's Accolade as its product innovation process andproduct portfolio management solution. Timex recently completed enterprise-wideimplementation of the system across all departments and to executive managementin a rollout that took approximately 60 days.Connecticut-based Timex was founded in 1854. It sells more than 30 millionwatches annually. The privately held company employs 7500 people at facilitieslocated in the U.S., South America, Europe and Asia.Timex operates in a fiercely competitive industry where ever-shorter productlife cycles have made continuous technology innovation critical to marketsuccess. Faced with the emergence of alternative timekeeping devices such ascell phones, PDAs and computers, Timex has continued to innovate and evolve itscore lines while expanding its product portfolio to include multi-functionwrist pagers, compasses, heart monitors and thermometers.Timex's implementation of Sopheon's Accolade system is integral to thecompany's adoption of Stage-Gate, the widely used product developmentmethodology. Accolade is being used to automate the Stage-Gate process and toprovide decision-making support for management of the company's increasinglycomplex portfolio of products. A primary reason Timex selected the Sopheonsolution is that it is specifically designed to support stage- or phase-basedproduct development processes and has proven capacity to strengthen processgovernance and throughput. Other considerations included the software'sease-of-use, its simple configurability and the speed with which it can beimplemented"We set a very aggressive timetable for our rollout of Accolade," said BerndBecker, vice president of product development at Timex. "Given the complexityof the implementation and the level of configuration required, I never expectedthat Sopheon would finish on time. But they did-in just two months and with nostart-up issues. Some of the first reactions to Accolade came from seniormanagement. They were immediately impressed by the level of detailedinformation the system gave them, and the ease with which that informationcould be accessed. With Accolade in place across our organization, we are doinga better job of managing our R&D investments, and we are fully realizing thebenefits of Stage-Gate. Sopheon and Accolade were clearly the right choice.""Most of the companies we deal with have identified innovation as a topstrategic priority and are acting with urgency," said Andy Michuda, chiefexecutive officer of Sopheon. "We give our clients the advantage of a systemthat is easy to implement, and customer service support that emphasizes workingsmart and fast without a lot of involvement by internal IT to deliver asolution that maps precisely to the adopting organization's requirements. Timexhad a clearly defined process and was very savvy about what they wanted toaccomplish through our software. As a result, we were able to hit the groundrunning and, working closely with their team, put a fully automated,world-class innovation system in place in a matter of weeks. For the client,this translates into accelerated time-to-value and a sustainable source ofimportant competitive advantage."Sopheon Accolade‚® is a registered trademark of Sopheon plc.Timex is a registered trademark of the Timex Corporation.Stage-Gate is a registered trademark of the Product Development Institute.All other trademarks and registered trademarks are the soleproperty of their respective owners.About TimexFounded in 1854, Timex is a privately owned company with manufacturing plantsand company offices in over 80 countries around the world. With more thanone-billion watches bearing the Timex brand sold world-wide, the TimexCorporation has been providing innovative, well-designed, and reliabletimepieces for over 150 years. For more information, please visit www.timex.comAbout SopheonSopheon (LSE: SPE) is an international provider of software and services thathelp organizations improve the business impact of product innovation. TheSopheon Accolade‚® product innovation process and portfolio management systemautomates gate- or phase-based product development processes and providesstrategic decision support that allows companies to increase revenue andprofits from new products. Sopheon is listed on the AIM Market of the LondonStock Exchange and on the Euronext in the Netherlands. For more information,please visit www.sopheon.com.Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Andrew Tan Hansard Communications Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Frank Jansen Citigate First Financial Tel : + 31 (0) 205 754 010ENDSOPHEON PLC
Date   Source Headline
11th Apr 20167:00 amRNSDirectors Options and Shareholding
21st Mar 20167:00 amRNSAmendment to Terms of Convertible Loan Stock
17th Mar 20167:00 amRNSFinal Results
21st Jan 20168:29 amRNSAccolade Release 10.2
8th Jan 20167:00 amRNSTrading Update and Board Change
20th Oct 20159:33 amRNSDirector Dealing
19th Oct 20157:00 amRNSDirector Dealing
9th Oct 20153:41 pmRNSDirector Dealing
9th Oct 20151:12 pmRNSDirector Dealing
2nd Oct 20153:39 pmRNSDirector Dealing
23rd Sep 20157:00 amRNSAccolade Release 10.1
27th Aug 20157:01 amRNSHalf Yearly Report
1st Jul 20157:00 amRNSDirector Shareholding
10th Jun 20151:44 pmRNSResult of AGM
10th Jun 20157:00 amRNSAGM Statement
2nd Jun 20157:00 amRNSAccolade 10.0 release
15th May 20153:10 pmRNSNotice of AGM
7th May 201511:40 amRNSDIRECTOR SHAREHOLDING
23rd Apr 201511:10 amRNSDirector Shareholding
20th Apr 201511:43 amRNSDirector Shareholding
13th Apr 20152:03 pmRNSHolding(s) in Company
10th Apr 201511:05 amRNSHolding(s) in Company
8th Apr 20157:00 amRNSDELISTING FROM ALTERNEXT AMSTERDAM
19th Mar 20157:00 amRNSFinal Results
20th Feb 20157:00 amRNSSopheon Releases Accolade® 9.3
5th Feb 20154:12 pmRNSChange of Registered Office
28th Jan 20157:00 amRNSTrading Update
19th Dec 201410:30 amRNSResult of General Meeting
12th Dec 20143:00 pmRNSTrading Update
2nd Dec 20144:00 pmRNSProposed Share Subdivision
2nd Dec 20147:00 amRNSDirector/PDMR Shareholding
27th Oct 20144:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20143:45 pmRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSDirector/PDMR Shareholding
17th Oct 20141:50 pmRNSDirector/PDMR Shareholding
10th Oct 201411:15 amRNSResult of GM and Further re Share Consolidation
24th Sep 20147:00 amRNSAccolade 9.2 Release
12th Sep 20147:00 amRNSShare Consolidation
28th Aug 20147:00 amRNSHalf Yearly Report
11th Jun 201412:20 pmRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
2nd Jun 20147:00 amRNSAmendment To The Terms Of Convertible Loan Stock
22nd May 20147:00 amRNSAlternext Amsterdam
1st May 20147:00 amRNSInterim Management Statement
22nd Apr 20147:01 amRNSSopheon Delivers Accolade Release 9.1
11th Apr 20147:00 amRNSWind Down Of Alternext Amsterdam
20th Mar 20147:01 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results
6th Mar 20147:00 amRNSNew Debt Facility
29th Jan 20148:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.